Related Experiment Video
Updated: Oct 1, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells
Gaël A Millot1, William Vainchenker, Dominique Duménil
1INSERM U362, Laboratoire Hématopoïèse et Cellules Souches, Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France. millot@ijm.jussieu.fr
Abstract:
Thrombopoietin (TPO) plays a critical role in megakaryopoiesis through binding to its receptor Mpl. This involves activation of various intracellular signaling pathways, including phosphoinositide 3-kinase (PI3K) and the mitogen-activated protein kinase (MAPK) pathways. Their precise role in TPO-mediated proliferation, survival and differentiation is not fully understood. In the present study, we show that TPO induces different biological responses in Mpl-transduced BaF-3 cells, depending on the cell surface density of Mpl and the resulting activation level of signaling pathways. TPO mediates cell proliferation in cells expressing high levels of Mpl but only mediates survival without proliferation in cells expressing low levels of the receptor. By using the kinase inhibitors PD98059 and LY294002, we further showed that the activation level of the PI3K and MAPK p42/44 pathways is a determining factor for the proliferative effect. In cells expressing low levels of Mpl, the survival effect was strongly dependent on the activation level of the PI3K/AKT, but not the MAPK p42/44 pathway. Moreover, this effect was correlated with the phosphorylation level of BAD but not with the expression level of Bcl-X(L). However, PI3K pathway inhibition did not increase apoptosis when BaF-3 cells proliferated in response to TPO, indicating a compensating mechanism from other Mpl signaling pathways in this case.
Insights
Thrombopoietin (TPO) signaling via Mpl receptor impacts cell fate. TPO drives proliferation at high Mpl levels but only survival at low levels, dependent on PI3K/AKT pathways.
Area of Science:
- Hematology
- Cell Biology
- Molecular Biology
Background:
- Thrombopoietin (TPO) is crucial for megakaryopoiesis, regulating blood platelet production.
- TPO exerts its effects by binding to the Mpl receptor, activating intracellular signaling pathways like PI3K and MAPK.
- The precise roles of these pathways in TPO-mediated cell proliferation, survival, and differentiation remain incompletely understood.
Purpose of the Study:
- To investigate how varying Mpl receptor expression levels influence TPO-induced biological responses in BaF-3 cells.
- To elucidate the specific roles of phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways in TPO-driven cell proliferation and survival.
Main Methods:
- Utilized Mpl-transduced BaF-3 cells with differing Mpl surface densities.
- Employed kinase inhibitors PD98059 (MAPK inhibitor) and LY294002 (PI3K inhibitor) to assess pathway involvement.
- Analyzed cell proliferation, survival, and the phosphorylation status of key proteins like BAD and expression of Bcl-X(L).
Main Results:
- TPO induced proliferation in cells with high Mpl density, but only survival (without proliferation) in cells with low Mpl density.
- Proliferative effects were dependent on the activation levels of both PI3K and MAPK p42/44 pathways.
- Survival effects in low Mpl-expressing cells were primarily dependent on PI3K/AKT pathway activation, correlating with BAD phosphorylation but not Bcl-X(L) expression.
- PI3K inhibition did not increase apoptosis during TPO-induced proliferation, suggesting compensatory signaling mechanisms.
Conclusions:
- Mpl receptor density dictates TPO's biological outcome, modulating proliferation versus survival.
- The PI3K and MAPK pathways play distinct, dose-dependent roles in TPO signaling.
- PI3K/AKT signaling is critical for TPO-mediated survival in Mpl-low cells, while compensatory mechanisms exist during proliferation.
Related Concept Videos
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Intracellular Signaling Affects Focal Adhesions
Some...

